Free patient guide · 19 pages · PDF

Stem Cell Therapy for Headaches & Migraines: A Patient's Guide

Targeting the Root Causes of Chronic Headache Disorders

Last updated: 2026-09-01 · Medically reviewed by SCL Medical Team

Download the free PDF (19 pages)Book a free consultation

What is inside this guide

Understanding Chronic Headaches & Migraines
How Stem Cell Therapy Helps
Treatment at StemCell Longevita
Results & Recovery
Getting Started

Chapter 1

Understanding Chronic Headaches & Migraines

What Are Chronic Migraines?

Chronic migraine is defined as headache occurring on 15 or more days per month, with at least 8 days having migraine features. Migraines involve complex neurological processes including cortical spreading depression, trigeminovascular activation, and neuroinflammation. Over 1 billion people worldwide experience migraines, making it the third most prevalent illness globally.

Impact on Quality of Life

Severe, debilitating head pain often accompanied by nausea, vomiting, and sensitivity to light and sound. Aura symptoms in 25-30% of patients, including visual disturbances, numbness, and speech difficulties. Chronic migraines are associated with depression, anxiety, and significant disability. Medication overuse headache can develop from frequent use of acute migraine medications. Neuroinflammation is increasingly recognized as a central driver of chronic migraine. Stem cell therapy's potent anti-inflammatory and neuroprotective properties directly target this underlying mechanism.

Chapter 2

How Stem Cell Therapy Helps

Neuro-Inflammatory Modulation

MSCs reduce neuroinflammation by modulating the release of inflammatory mediators including CGRP , substance P , and prostaglandins that drive migraine attacks. They also promote neural repair, improve cerebrovascular function, and reduce the hypersensitivity of pain processing pathways that characterize chronic headache disorders. Patients treated with MSC therapy for chronic migraines reported an average 62% reduction in headache frequency and 55% reduction in pain intensity at 6-month follow-up in pilot clinical studies.

Observed Outcomes

62%: Reduction in Headache Frequency
55%: Reduction in Pain Intensity
71%: Reduced Medication Need

Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.

Chapter 3

Treatment at StemCell Longevita

Our Migraine Protocol

We combine IV stem cell infusion for systemic anti-inflammatory effect with targeted treatments based on headache type. For migraine, treatment may include intrathecal administration for direct neurological access. Treatment is personalized based on headache type, frequency, triggers, and current medications.

Treatment at Liv Hospital Ulus

Day 1 — Neurological evaluation, headache diary review, and diagnostic assessment.
Day 2 — Stem cell administration via appropriate route (IV and/or intrathecal).
Day 3 — Follow-up assessment and discharge with headache management plan.

Chapter 4

Results & Recovery

Expected Timeline

Headache frequency and severity typically begin decreasing within 4 to 8 weeks. Maximum benefits are usually achieved by 3 to 6 months. Many patients are able to reduce or discontinue preventive medications under medical supervision.

4-8: Weeks to Improvement
75%: Significant Headache Reduction
12-18: Months of Sustained Relief

Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.

Chapter 5

Getting Started

Next Steps

If you suffer from chronic headaches or migraines that have not responded to conventional treatments, contact us with your headache history and current treatment regimen for a free evaluation.

Frequently asked questions

While stem cell therapy may not provide a permanent cure, many patients experience dramatic and sustained reductions in migraine frequency and severity lasting 12 to 18 months, with some achieving long-term remission.

Many patients are able to significantly reduce their preventive medications. Acute treatments may still be needed for occasional headaches, but the frequency and severity are typically much reduced.

Not always. Some patients respond well to IV infusion alone. The decision to include intrathecal delivery depends on the severity and nature of your headache disorder. Our neurologist will recommend the optimal approach.

Most patients undergo one initial treatment course. Booster treatments may be recommended every 12 to 18 months depending on your response.

Next steps

Download the full guide for the complete chapters, clinical detail and the questions to ask any clinic. Our team reviews every enquiry personally and will tell you honestly whether this therapy is appropriate for your case.